drugset / Trial / NCT07073092

Propolis for Management of Chemotherapy-Induced Oral Mucositis in Pediatric Patients

NCT07073092

Phase 2 Not yet recruiting 50 enrolled Ain Shams University
RandomizedParallel-groupSingle-blindPrevention

Summary

The goal of this clinical trial is to evaluate the efficacy of propolis in the prevention of oral mucositis and reducing pain score in children undergoing chemotherapy, and assessing its impact on body mass index, pediatric quality of life and total antioxidant assay. The main question it aims to answer is: What is the effect of propolis on oral mucositis scores in children undergoing chemotherapy? Participants will: Take propolis 3 times daily for 21 days follow up weekly for 3 weeks

Timeline

Start
2025-07-15
Primary completion
2025-12-30
Completion
2026-01-30

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject PROPOLIS WAX Traditional medicine (herbal / TCM)
Background Chlorohexidine Unknown Other